Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of autoantibodies. However, the underlying cause of disease appears to relate to defects in T cell tolerance or T cell help to B cells. Transgenic (Tg) mice overexpressing the cytokine B cell -activating factor of the tumor necrosis factor family (BAFF) develop an autoimmune disorder similar to SLE and show impaired B cell tolerance and altered T cell differentiation. We generated BAFF Tg mice that were completely defi cient in T cells, and, surprisingly, these mice developed an SLE-like disease indistinguishable from that of BAFF Tg mice. Autoimmunity in BAFF Tg mice did, however, require B cellintrinsic signals through the Toll-like receptor (TLR) -associated signaling adaptor MyD88, which controlled the production of proinfl ammatory autoantibody isotypes. TLR7/9 activation strongly up-regulated expression of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), which is a receptor for BAFF involved in B cell responses to T cell -independent antigens. Moreover, BAFF enhanced TLR7/9 expression on B cells and TLR-mediated production of autoantibodies. Therefore, autoimmunity in BAFF Tg mice results from altered B cell tolerance, but requires TLR signaling and is independent of T cell help. It is possible that SLE patients with elevated levels of BAFF show a similar basis for disease.
Systemic lupus erythematosus (SLE) is a chronic infl ammatory autoimmune disorder that aff ects various tissues, particularly the skin and kidney ( 1, 2 ) . Disease pathogenesis is characterized by the production of a range of autoantibodies, in particular antinuclear antibodies (ANA) ( 1 ) . Treatment of SLE still relies on broad immunosuppressants, such as corticosteroids and hydroxychloroquine sulfates ( 3, 4 ) . Although these treatments have been improved, they remain ineffi cacious in some SLE patients, suggesting that alternative or unappreciated immune mechanisms may be operating.
Autoantibody-producing B cells appear central to the pathogenesis of SLE. Many mechanisms have been proposed to explain their appear ance, from impaired survival/apoptosis signals preventing negative selection ( 5 ) , to dysfunctional complement or inhibitory Fc receptors ( 6, 7 ) , to activation of Toll-like receptors (TLRs) in response to accumulation of apoptotic bodies ( 8, 9 ) . However, substantial evidence indicates that T cells are important players in SLE ( 2, 10, 11 ) . Inhibition of T cell activation or T -B cell interaction is an eff ective way to prevent autoimmunity in several animal models of SLE ( 12, 13 ) . More recently, mutation of the Roquin gene, which specifi cally perturbs the function of follicular helper T cells, induces development of SLE in mice ( 14 ) . In humans, various HLA haplotypes have been associated with susceptibility to SLE ( 2, 10 ) . T cell signaling in SLE patients can be abnormal, and analysis of anti-DNA autoantibodies has revealed somatic mutations, which are suggestive of T cell -dependent affi nity maturation ( 2, 10 ) . B cell -depleting reagents, such as Rituximab, have shown promising therapeutic effi cacy in SLE clinical trials ( 15 ) . It is still unclear whether this effi cacy is caused by reduced autoantibody production or by the depletion of aff ected ( Fig. 1 A ) . Eff ector T cell expansion occurs before disease onset and depends on the presence of B cells ( 26 ) . Therefore, we hypothesized that in BAFF Tg mice alteration of the B cell compartment leads to a change in the makeup of the T cell compartment and, combined, these changes contribute to the development of high-affi nity autoantibodies and, ultimately, autoimmune disease. Changes in T cells that might aff ect peripheral tolerance include inappropriate activation of autoreactive T cells, or impaired regulatory T cell (T reg cell) function. Unexpectedly, we found that the proportion of T reg cells was signifi cantly elevated in the peripheral LNs (PLNs) of BAFF Tg mice ( Fig. 1 B ) . Absolute numbers of T reg cells were increased in the spleen, PLN, and thymus, which is suggestive of a change in T reg cell production ( Fig. 1 C ) . The consequence of increased numbers of eff ector and T reg cell numbers in BAFF Tg mice is uncertain, but it does suggest a role of T cells in BAFF-mediated autoimmune disease.
B cells with potent antigen-presenting cell (APC) function for T cells, or both. Despite the obvious pathogenic role of antibodies and B cells, the corruption of T cell tolerance has been considered an important underlying defect in antibodymediated systemic autoimmune diseases ( 2, 16 ) .
B cell -activating factor of the TNF family (BAFF; also termed TNFSF13b and BLyS) is a TNF-like cytokine that is essential for the maturation and survival of peripheral B cells ( 17, 18 ) . BAFF transgenic (Tg) mice develop autoantibodies, leading to nephritis and salivary gland destruction, features that are reminiscent of SLE and Sj ö gren ' s syndrome (SS), respectively ( 19, 20 ) . Elevated BAFF levels are detected in some human autoimmune conditions, including SLE ( 18, 20 ) . Like most SLE mouse models, disease in BAFF Tg mice correlates with clear abnormalities of the B cell compartent, leading to inappropriate BAFF-induced survival of selfreactive B cells ( 21 ) . Moreover, we have shown that marginal zone (MZ) and B1 B cells may play tissue-specifi c roles in the pathogenesis of SLE in BAFF Tg mice ( 20, 22, 23 ) . We have studied the eff ect of excess BAFF on B cell tolerance using hen egg lysozyme (HEL) B cell receptor (BCR) knock-in mice, combined with HEL/BAFF Tg mice. In this system, negative selection of self-reactive B cells was mostly normal, with expansion of only a subset of low-affi nity, HELspecifi c B cells, with many of these being MZ B cells ( 24 ) . Thus, the relevance of low-affi nity, self-reactive B cells in BAFF-mediated autoimmunity is questionable, suggesting an additional pathogenic contribution from T cells and/or from innate immune signals. BAFF costimulates T cells and promotes T cell diff erentiation to eff ector cells ( 25 ) , and increased numbers of eff ector T cells are present in BAFF Tg mice ( 26 ) . Therefore, we hypothesized that the BAFF Tg model is similar to many mouse models of SLE, with the likely combined involvement of both B and T cells in the disease process.
To determine the role of T cells in BAFF-driven autoimmune disease, we crossed BAFF Tg mice onto mice lacking both ␣ / ␤ and ␥ / ␦ T cells ( 27 ) and looked for signs of autoimmunity. Surprisingly, the resulting T⌬-BTg mice were capable of producing proinfl ammatory autoantibodies and developed autoimmunity with the same severity as BAFF Tg mice. Although IgA autoantibody production was T cell dependent, it was dispensable for disease progression. We found that BAFF promoted TLR7/9 expression in B cells and TLR-induced production of autoantibodies, and that disease in BAFF Tg mice required B cell -intrinsic TLR-associated MyD88 signaling. Therefore, BAFF-induced SLE-like disease in BAFF Tg mice is a T cell -independent process, but requires innate immune signals through MyD88 for B cell activation and production of pathogenic autoantibodies.
RESULTS

Altered T cell constitution in BAFF Tg mice
In BAFF Tg mice, total numbers of T cells are not changed ( 19 ) , although there is an increased proportion of eff ector T cells ( 19, 26 ) . The CD8 ϩ T cell compartment is also signifi cantly , available at http://www.jem.org/cgi/content/full/ jem.20062567/DC1). Splenomegaly, which is a typical feature of BAFF Tg mice, was unchanged in T⌬-BTg mice ( Fig. 2 A ) . Analysis of absolute numbers of transitional type 2 MZ (T2-MZ), T2 follicular (T2-Fo), MZ, and Fo B cells in the spleen, as well
Expansion of the B cell compartment in BAFF Tg mice is T cell independent
To address the role of T cells in the SLE disease seen in BAFF Tg mice, we crossed BAFF Tg mice onto TCR Ϫ/Ϫ mice ( 27 ) and generated BAFF Tg mice lacking T cells (T⌬-BTg; However, similar to TCR Ϫ/Ϫ mice, affi nity maturation was impaired in T⌬-BTg mice, as tested by measuring antibody titers in a low-density, hapten-coated BSA ELISA (unpublished data).
BAFF promotes isotype switching to IgA ( 29, 30 ) , and BAFF Tg mice produce higher levels of IgA in response to both T cell -independent and -dependent antigens ( Fig. 3, A and B ). T⌬-BTg mice, in contrast, retained an IgA response to a T cell -independent antigen ( Fig. 3 A ) , but not to the T cell -dependent antigen NP-OVA. Thus, in the absence of T cells, excess production of BAFF can allow partial class switching to Ig isotypes that are normally dependent on the presence of T cell help. In addition, BAFF-induced switching to IgA in response to T cell -dependent, but not T cellindependent, antigens relies on T cell help in vivo.
Production of IgA, but not IgG and IgM, autoantibodies is T cell dependent in BAFF Tg mice Antibody reactivity with double-stranded (ds) DNA is associated with development of SLE ( 33, 34 ) . Switching to IgG2a and IgG2b autoantibodies is linked to pathogenicity ( 35 -37 ) , whereas IgM anti-DNA antibodies, per se, are insuffi cient for disease ( 38 ) . Studies that have described a pathogenic role for IgG2a in C57BL/6 animal models ( 35 ) were most likely measuring IgG2c (an isotype recognized by most commercial anti-IgG2a reagents) because in C57BL/6 mice the IgG2a gene is deleted ( 39 ) . As T cells are thought necessary for development of the switched anti-DNA antibodies in SLE ( 10, 34 ), we investigated whether T⌬-BTg mice developed autoantibodies similar to those seen in BAFF Tg mice. Levels as B1a, B1b, and Fo B cells in the peritoneal cavity (PerC), B cell subsets that are particularly expanded in BAFF Tg mice ( 21 ) , revealed no diff erence between BAFF Tg and T ⌬ -BTg mice ( Fig. 2 B ) . In BAFF Tg mice, a high proportion of MZlike B cells have been detected in the blood and PLNs ( 21 ), and we saw a similar expansion of this population in T ⌬ -BTg mice ( Fig. 2 C ) . Levels of total serum IgG2c, IgG2b, IgG3, and IgM were increased similarly in T ⌬ -BTg mice, as in BAFF Tg mice ( Fig. 2 D ) . IgG1 levels and, most importantly, IgA levels are elevated in BAFF Tg mice ( 28 ) , possibly as a result of BAFF-induced isotype switching to IgA ( 29, 30 ) . Interestingly, the levels of these two isotypes were normal in T⌬-BTg mice ( Fig. 2 D ) , suggesting a role for T cells in addition to that of BAFF in the augmentation of IgA and IgG1 levels seen in BAFF Tg mice. Similarly, fecal IgA levels, which are elevated in BAFF Tg mice ( 19, 23 ) , were normal in T⌬-BTg mice (unpublished data). As expected, germinal centers were absent in T⌬-BTg mice, which is similar to T cell -defi cient control mice (unpublished data). In conclusion, expansion of the B cell compartment in BAFF Tg mice was T cell independent, resulting from a direct survival eff ect of BAFF on B cells, followed by B cell activation, whereas increased total serum IgG1 and IgA levels in BAFF Tg mice depended on T cell help.
Elevated IgG2c and IgG2b levels in T⌬-BTg mice in response to T cell -dependent soluble antigen BAFF promotes B cell activation ( 31 ) and BAFF Tg mice mount enhanced responses to immunization with both T cell -independent and -dependent antigens ( 22, 23 ) . BAFF is involved in isotype class switching, although this eff ect is often weak without additional T cell -dependent signals, such as CD40 ligand (CD40L) or T cell -derived cytokines ( 29, 30 ) . Using our T⌬-BTg mouse model, we addressed the contribution of T cell help in BAFF-mediated isotype class switching in vivo. As expected, antibody responses to the T cellindependent antigen nitrophenyl (NP)-Ficoll is essentially similar in BAFF Tg and T⌬-BTg mice, and increased compared with WT and TCR Ϫ/Ϫ mice, respectively ( Fig. 3 A ) . The higher levels of NP-specifi c IgG1, IgG2c, and IgG2b seen in NPFicoll -immunized BAFF Tg and T⌬-BTg mice is intriguing because switching to these isotypes is characteristic of a response to T cell -dependent antigens ( 32 ) .
To test whether excess BAFF may, in part, help B cells overcome the need for the T cell -derived signals required for isotype switching, we tested the response of T⌬-BTg mice to immunization with a soluble T cell -dependent antigen. The antibody response to the T cell -dependent soluble antigen NP-OVA given with adjuvant was impaired in T⌬-BTg mice ( Fig. 3 B ) . However, signifi cantly elevated levels of NP-specifi c IgG2c and IgG2b were detected in T⌬-BTg mice compared with TCR Ϫ/Ϫ mice ( Fig. 3 B ) , indicating that excess BAFF in T⌬-BTg mice was able to partially support isotype switching to NP-specifi c IgG2c and IgG2b, a process that is normally dependent on the presence of T cells ( 32 ) and totally impaired in TCR Ϫ/Ϫ mice ( Fig. 3 B ) . 
T⌬-BTg mice develop severe autoimmune features indistinguishable from those of BAFF Tg mice
As T⌬-BTg mice are capable of producing autoantibodies of isotypes known to correlate with pathogenicity ( Fig. 4 ) ( 35, 37 ) , we monitored these mice for features of autoimmunity and tissue destruction, as previously described for BAFF Tg mice ( 19, 20 ) . At 12 mo of age, similar elevated levels of proteinuria were detected in both BAFF Tg and T⌬-BTg mice ( Fig. 5 A ) , which is indicative of progressing nephritis. Histochemical staining of kidney sections from both BAFF Tg and T⌬-BTg mice revealed nephritis, which is characterized by abnormally enlarged and segmented glomeruli and large infi ltrates of mononuclear cells ( Fig. 5 B ) . Examination of Ig deposits in the kidneys of BAFF Tg mice revealed abundant IgM, IgA, and IgG deposits ( Fig. 5 C ) . IgG deposits were predominantly IgG2c, IgG2b, and IgG3 ( of IgM and IgG anti -single-stranded (ss) DNA, dsDNA, and rheumatoid factor (RF) autoantibodies were comparable in T⌬-BTg and BAFF Tg mice ( Fig. 4 A ) . Within the IgG repertoire, autoantibodies in T⌬-BTg mice were predominantly IgG2c, IgG2b, and IgG3 isotypes (Fig. S2 , A and B, available at http://www.jem.org/cgi/content/full/jem.20062567/DC1). IgA autoantibodies were not detected in T⌬-BTg mice ( Fig.  4 A ) . Specifi cities of ANA and anti-dsDNA antibodies were further characterized using serum samples to stain slides carrying Hep-2 and Crithidia luciliae , respectively ( Fig. 4 B ) . This staining confi rmed the absence of IgA autoantibodies in T⌬-BTg mice, in contrast to BAFF Tg mice. The staining pattern of BAFF Tg -derived IgA autoantibodies on Hep-2 slides was granular and cytoplasmic, indicating reactivity to RNA complexes ( Fig. 4 B ) ( 40 ) . The staining pattern of all autoantibody isotypes from BAFF Tg mice on C. luciliae slides was characteristic of kinetoplast staining, confi rming detection of dsDNA ( Fig. 4 B ) . Although IgA autoantibody production was absent in T⌬-BTg mice, the staining pattern observed with the remaining autoantibody isotypes was unchanged ( Fig. 4 B ) . Collectively, data in Fig. 2 D and Fig. 4 suggest that elevated production of IgA seen in BAFF Tg mice is not solely related to the role of BAFF in IgA class-switching ( 29, 30 ) , but also requires the presence of T cells. Nevertheless, activation of autoreactive B cells in BAFF Tg mice is a T cell -independent process. T⌬-BTg mice suff er from the same signs of infl ammation and tissue destruction ( Fig. 5 E ) , which are characterized by decreased saliva production ( Fig. 5 F ) , as was previously shown in BAFF Tg mice ( 20 ) . Infi ltration of MZ-like B cells into the cervical LNs (CLNs) and salivary gland ( 20 ) was identical in both BAFF Tg and T⌬-BTg mice ( Fig. 5 G ) . IgA, IgM, and IgG deposition were also detected in the salivary gland of BAFF Tg mice, but only IgM and IgG deposits were detected in the same tissues from T⌬-BTg mice ( Fig. 5 H ) . IgG deposits were primarily IgG2c, IgG2b, and IgG3, with no IgG1 seen in salivary glands from T⌬-BTg mice (Fig. S3 B) . Thus, BAFF Tg mice have severe autoimmune pathology that develops independently of T cells, but concomitantly with production and deposition of autoantibodies in aff ected tissues.
B cell activation and autoantibody production in BAFF Tg mice requires MyD88-dependent signaling Because a severe autoimmune disease develops in T celldefi cient BAFF Tg mice, alternative pathogenic mechanisms must be responsible for self-reactive B cell activation. We previously showed an expansion of the MZ and B1 B cell compartment in BAFF Tg mice ( 21, 23 ) , and found the same for T⌬-BTg mice ( Fig. 3 B ) . MZ and B1 B cells are considered innate B cells with self-reactive properties, and they are particularly responsive to activation via TLRs ( 42 -45 ) . In addition, BAFF can enhance TLR-mediated B cell activation and Ig class switching in human B cells ( 45 ) . Recent studies revealed that TLR7/9 may play a dominant role in SLE, although their role varies depending on the model under investigation ( 8, 46, 47 ) . Using FACS-sorted, unswitched mouse B cells, we found that BAFF promoted TLR9-i nduced, but not TLR7-induced, isotype switching from IgM to IgG in vitro (Fig. S4, A and B, available at http://www.jem.org/cgi/ content/full/jem.20062567/DC1). This may be a mechanism whereby BAFF specifi cally exacerbates self-reactive B cell activation via TLR9.
Stimulation of FACS-sorted WT Fo, MZ, B1a, and B1b B cells with TLR ligands showed that both TLR7 (R848) and TLR9 (CpG), but not TLR4 (LPS), activation led to a strong up-regulation of one of the three BAFF receptors, TACI, on Fo and MZ B cells ( Fig. 6 A ) . TLR7/9 stimulation also increased TACI expression on B1 B cells, although TLR7 activation was more potent than that of TLR9 ( Fig. 6 A ) . TLR7/9 activation also led to up-regulation of the most widely expressed BAFF receptor (BAFF-R), although this was weaker and mostly restricted to Fo and MZ B cells ( Fig. 6 A ) . These results confi rm a recent independent study ( 48 ) . Therefore, TLR7/9 activation in B cells strongly up-regulates the expression of TACI, a receptor that is essential for the response of B cells to T cell -independent antigens ( 49 ) . Moreover, BAFF stimulation of sorted Fo, MZ, and B1 B cells in culture leads to a strong up-regulation of TLR7/9 expression on Fo and MZ, but not B1, B cells (Fig. S4 C) .
Work by us and others demonstrated a role for MZ B cells in the pathogenesis of autoimmunity in BAFF Tg mice ( 20, 23, 50 ) . We sorted splenic Fo, MZ, and peritoneal B1 B cells from BAFF Tg mice and cultured these cells with various TLR ligands, which were supplemented or not with exogenous recombinant BAFF, and measured total anti-dsDNA autoantibody levels in the supernatant. BAFF Tg -derived Fo B cells failed to produce anti-dsDNA autoantibodies under any of the conditions tested (unpublished data). Both BAFF Tg-derived MZ and B1 B cell populations contained autoantibody-producing cells in response to TLR stimulation ( Fig. 6, B and C ) . Activation of anti-DNA -producing, BAFF Tg -derived MZ and B1 B cells was increased in vitro in response to TLR4-, TLR9-, and TLR7-specifi c ligands. The addition of BAFF to these cultures further stimulated TLR9-induced production of anti-dsDNA autoantibodies by both MZ and B1 B cell cultures ( Fig. 6, B and C ) , and TLR2-and TLR3-induced autoantibody production in B1 B cell cultures ( Fig. 6 C ) . Thus, MZ and B1, but not Fo, B cells are the source of anti-dsDNA autoantibodies in BAFF Tg mice, and BAFF-enhanced autoantibody production occurs in response to stimulation through TLR9 in particular. Collectively, these results suggest cooperation between BAFF and TLR9 as the dominant driver of self-reactive MZ B cell activation in BAFF Tg mice. A more complex BAFF -TLR2/3/9 cooperation exists for B1 B cells.
Most TLRs, as well as receptors for IL-1 -related cytokines, recruit the signaling adaptor MyD88 upon activation ( 51 -53 ) . The BAFF transgene is liver-specifi c, allowing us to adoptively transfer BM from WT or MyD88 Ϫ/Ϫ mice into lethally irradiated WT or BAFF Tg mice. 12 wk after reconstitution, a clear reduction in B cell activation was observed in BAFF Tg mice reconstituted with MyD88 Ϫ/Ϫ BM compared with MyD88 ϩ/ϩ BM ( Fig. 7 A ) . We also observed a loss of all autoreactive IgG isotypes ( Fig. 7 B ) and reduced IgM, but similar IgA, levels ( Fig. 7 B ) , which is consistent with the T cell -dependent nature of autoreactive IgA production seen in T⌬-BTg mice ( Fig. 2 D and Fig. 4 ) . Total IgG2c and IgG2b levels in the blood of MyD88 Ϫ/Ϫ BM -reconstituted mice were restored to normal, but IgA levels remained elevated (Fig. S5 B, available at http://www.jem.org/cgi/content/full/ jem.20062567/DC1). We examined Ig deposition in the kidneys of these animals and observed pronounced IgA and some IgM deposits, but no IgG, including the pathogenic IgG2c and IgG2b isotypes ( Fig. 7 C and Fig. S5 A) . Interestingly, lack of IgG deposition in the kidneys correlated with greatly reduced C3 deposition in the glomeruli and suggested an inhibition of complement-activated infl ammation in the kidneys ( Fig. 7 D ) . Although IgM alone is not pathogenic ( 38 ), the C3-fi xing ability of the remaining IgA deposits remains unclear. BAFF Tg mice reconstituted with MyD88 Ϫ/Ϫ BM failed to develop proteinuria (unpublished data). In conclusion, MyD88-mediated signaling was essential for the production of autoantibodies of the IgG2c/b isotype, which were previously described as pathogenic in murine SLE ( 35, 37 ) .
Two TLR-dependent mechanisms have been advanced to explain autoimmunity in SLE ( 8 ) . The fi rst involves direct activation of TLRs in self-reactive B cells. The second involves activation of TLRs in plasmacytoid DCs (pDCs), which in turn exacerbate autoimmune responses through production of type I IFNs ( 8, 9 ) . Numbers of splenic myeloid DCs (mDC) and pDCs were increased in BAFF Tg mice compared with control mice (Fig. S5 C) . However, these numbers correlated with the extent of splenomegaly (unpublished data). In addition, we saw no augmentation of mDC or pDC activation (expression of MHC class II and CD80) in BAFF Tg mice when compared with WT control cells (Fig. S5 C) . The same observation was made for mDCs and pDCs in BAFF Tg mice reconstituted with MyD88 ϩ/ϩ or MyD88 Ϫ/Ϫ BM (Fig. S5 D) . We were also unable to detect IFN ␣ in the serum of all of these mice (unpublished data). The eff ector T cell compartment was not expanded in MyD88 Ϫ/Ϫ -reconstituted BAFF Tg mice (Fig. S5 E) , suggesting that this eff ect was not merely B cell -dependent ( 26 ), but also dependent on MyD88 signaling in B cells. BAFF production was not impaired in MyD88 Ϫ/Ϫ mice; in fact, BAFF levels were slightly elevated in the serum of these mice compared with WT animals (Fig. S4 D) . This result is consistent with the elevated expression of CD23 seen on MyD88 Ϫ/Ϫ B cells ( 54 ) , a molecule known to require BAFF for its expression ( 55 ) .
Lack of MyD88 can aff ect the function of innate cells in addition to that of B cells. To address this point, we reconstituted irradiated BAFF Tg mice with a 50:50 mix of MyD88 Ϫ/Ϫ and Rag1 Ϫ/Ϫ BM to repopulate the immune system of recipient BAFF Tg mice with MyD88-suffi cient innate cells in the presence of MyD88 Ϫ/Ϫ B cells. Macrophages derived from the BM of animals reconstituted with the Rag1 Ϫ/Ϫ /MyD88 Ϫ/Ϫ BM mix, but not those derived from MyD88 Ϫ/Ϫ -reconstituted BAFF Tg mice, produced TNF in response to LPS ex vivo (unpublished data), confi rming development of these cells from the Rag1 Ϫ/Ϫ BM source. Animals recon stituted with the Rag1 Ϫ/Ϫ / MyD88 Ϫ/Ϫ BM mix had slightly more IgG autoantibodies in the serum than MyD88 Ϫ/Ϫ BM -reconstituted mice ( Fig. 7 B ) . of B cells to IgA in a T cell -dependent and -independent fashion, particularly in MZ and B1 B cells, which are two expanded B cell subsets in BAFF Tg mice ( 18, 59 ) . However, this eff ect is potentiated by the addition of T cell -derived factors, such as CD40L and IL-4 ( 29, 59 ) . Therefore, it is likely that high IgA levels in BAFF Tg mice are the result of BAFF-induced switching to IgA potentiated by endogenous T cell -derived factors. It is important to note that although serum IgA levels are reduced in T⌬-BTg mice compared with BAFF Tg mice, these levels are normal compared with WT animals, supporting the notion that T cell -dependent, but not T cell -independent, production of IgA is exacerbated by excess BAFF production. Switching to IgG2c and IgG2b in response to T cell -dependent antigens occurs at low levels in T⌬-BTg mice. BAFF combined with IL-21 can stimulate switching of B cells to IgG as effi ciently as T cell -dependent signals, such as CD40L or IL-4 ( 60 ). Therefore, it is possible that excess BAFF in the presence of other endogenous cytokines, such as IL-21, may provide T cell -like signals, driving low levels of switching to IgG2c and IgG2b in T cell -defi cient BAFF Tg mice.
In view of the emerging role of TLR7/9 in SLE ( 8, 9, 57 ), TLR signaling was a candidate mechanism for disease progression in BAFF Tg mice. MZ and B1 B cells are often referred to as " innate " B cells and are particularly responsive to TLR activation ( 42 -44 ) . We showed that BAFF stimulation of Fo and MZ, but not B1, B cells strongly up-regulated TLR7/9 expression. In turn, activation of TLR7/9, but not of TLR4, strongly up-regulated TACI expression on B cells. TACI is a receptor for BAFF that is essential for B cell responses to T cell -independent antigens ( 49 ). Thus, a tight connection between TACI expression and TLR activation may be a central pathogenic mechanism in BAFF Tg mice ( Fig. 8 ) . In fact, TACI may play a role in the production of anti-chromatin autoantibodies ( 61 ) .
TLR9-mediated promotion of autoantibodies was exacerbated by BAFF in both BAFF Tg -derived MZ and B1 B cells. However, reconstitution of BAFF Tg mice with TLR9 Ϫ/Ϫ BM did not prevent the production of IgG autoantibodies and kidney infl ammation. As TLR7 activation has similar eff ects to TLR9 on TACI expression, it is possible that ablation of TLR9 has been compensated for by TLR7 activation. TLR9 is involved in the pathology of several, but not all, mouse models of SLE ( 50, 62 ) . For instance, in the MRL-lpr model, TLR9 has a protective role, and defi ciency in TLR9 exacerbates SLE ( 47 ) . This protection may occur, in part, via enhanced IL-10 production from TLR9-activated MZ B cells ( 44, 63 ) , a population that is also expanded in MRL-lpr mice ( 64 ) . In MRL-lpr mice lacking BAFF-R signaling, aspects of nephritis were more severe ( 65 ) . Whether this eff ect is linked to lack of MZ B cells in these mice is unclear.
In contrast to TLR9, TLR7 defi ciency has a protective eff ect in the MRL-lpr model ( 46, 47 ) . Yet, there is a major difference between this model and BAFF Tg mice. The MRLlpr model is T cell dependent ( 12 ) , whereas SLE in BAFF Tg mice, shown here, is not. In support of this diff erence, This suggests that MyD88 expression in innate cells plays some role in autoantibody production. However, similar to MyD88 Ϫ/Ϫ BM-reconstituted mice, animals reconstituted with the Rag1 Ϫ/Ϫ /MyD88 Ϫ/Ϫ BM mix did not show any IgG deposition or C3 fi xation in the kidney ( Fig. 7, C and D ) . Thus, MyD88 expression in B cells is likely an important element contributing to the pathogenic role of B cells in BAFF Tg mice.
Our in vitro work implicated a role for TLR9 and BAFF in autoantibody production. To address this point, irradiated BAFF Tg mice were reconstituted with TLR9 Ϫ/Ϫ or control TLR9 ϩ/ϩ BM. However, we observed no protection or differences in autoantibody production (Fig. S6 , available at http://www.jem.org/cgi/content/full/jem.20062567/DC1), or signs of kidney infl ammation (unpublished data), suggesting that disease in BAFF Tg mice does not rely solely on TLR9 signaling. In view of the equally important role of TLR7 in our system ( Fig. 6 A ) , extensive genetic approaches will need to be used to fully dissect TLR signaling in this system.
In conclusion, there was no evidence of mDC or pDC dysregulation in BAFF Tg mice; rather, lack of MyD88-mediated signaling directly aff ected B cell function, preventing pathogenic autoantibody-mediated kidney disease and eff ector T cell expansion.
DISCUSSION
Various mechanisms have been suggested as drivers of SLE. These include dysregulation of the innate immune system, overproduction of infl ammatory cytokines, and impaired B and T cell tolerance/regulation ( 2, 4, 56 ) . These mechanisms may be linked. For instance, accumulation of apoptotic cellderived nucleic acids can lead to TLR-dependent activation of pDCs, production of type I IFNs, which stimulate DC maturation and self-reactive T and B cell activation ( 8, 9, 57 ) . In addition, the activity of B cells as APCs for T cells may be important in corrupting immune tolerance in SLE ( 58 ) . Finally, the pathology in SLE appears closely linked to the costimulatory role of self-reactive T cells ( 10, 14, 16 ) . This model suggests a complex conspiracy between innate immunity, T cells, and B cells in SLE, and that disarming one contributor should infl uence disease pathogenesis. For instance, the B celldepleting mAb Rituximab ameliorates disease in many patients with SLE ( 15 ) and underscores the importance of B cells, either as initiators or as end-stage eff ectors, in the pathogenesis of human SLE.
In this study, we showed that overexpression of BAFF in mice led to the development of a T cell -independent form of SLE. This was a surprising result because the initial analysis of BAFF Tg mice was consistent with the accepted idea of T and B cell involvement in SLE, with excessive autoantibody production ( 19 ) and an expanded eff ector T cell compartment ( 19, 26 ) . These results are supported by other studies that showed that CD40 and germinal center formation were not required for disease in BAFF Tg mice ( 22, 23, 50 ) .
Although disease in BAFF Tg mice was T cell independent, T cells did augment IgA levels. BAFF can induce switching either, as it promotes Th2 cytokine release ( 53 ), whereas BAFF has been shown to oppose it ( 26 ) . IL-1 can costimulate B cell activation ( 67 ) and plays an important proinfl ammatory role in SLE ( 68 ) . Therefore, an IL-1 -mediated proinfl ammatory role in the glomerulonephritis of BAFF Tg mice is not excluded.
An intriguing question is how SLE-like disease is triggered in BAFF Tg mice. Cell death is an ongoing process in healthy individuals as part of cellular turnover, immune tolerance, and regulation, and also occurs as a result of infections. Therefore, cell-derived nuclear autoantigens are continuously present. In BAFF Tg mice, three events lead to autoimmunity: (a) failure of B cell tolerance during splenic maturation and accumulation of self-reactive B cells ( 24 ) , (b) up-regulation of TLR expression in B cells, and (c) MyD88-dependent B cell activation in the presence of high BAFF levels, promoting production of proinfl ammatory autoantibodies ( Fig. 8 ) . The production of IgG2a/c and IgG2b autoantibody isotypes is linked to kidney disease in our SLE model and others ( 35, 36 ) , and their production requires MyD88 in BAFF Tg mice.
Understanding the exact role of individual TLRs in mouse SLE is very much dependent on the SLE model under investigation. Of the many known mouse SLE models, the MRL-lpr, the Yaa , and the Roquin models have an important T cell component driving disease ( 14, 69 ) , and in the fi rst two models, TLR7, which stimulates IFN ␣ production by pDC, exacerbates T/B cell responses ( 47 ) . In contrast, in Fc ␥ RIIB Ϫ/Ϫ mice or mice expressing the Ly108.1 isoform, and in BAFF Tg mice, disease is linked directly to impaired B cell tolerance ( 38, 70 ) . Of the B cell -dependent SLE models, BAFF Tg mice are unique because self-reactive B cells are selected into the MZ B cell compartment ( 21, 24 ) and, possibly, the B1 B cell pools, both of which are particularly responsive to TLR activation, especially in the presence of BAFF ( 43, 44, 63 ) .
Our results describe a new mechanism leading to SLElike disease in mice, and highlight the diversity of separate disorders that can, by themselves, generate the same SLE-like syndrome. It will be a challenge to identify the various forms of SLE in humans, and whether they are T or B cell dominant, to allow new diagnostic approaches that are likely to help stratify SLE patients into groups with predictable responses to diff erent therapies. A logical extension of these fi ndings is to investigate whether human SLE patients with high serum BAFF levels have a similar MyD88-dependent and T cell -independent form of disease.
MATERIALS AND METHODS
Mice. BAFF Tg mice on a C57BL/6 background have been previously described ( 19 ) . Mice homozygous for both the TCR ␤ tm/Mom and the TCR ␦ tm/Mom -targeted mutations on a C57BL/6 background were purchased from The Jackson Laboratory ( 27 ) . BAFF Tg x ␤ ␦ TCR Ϫ/Ϫ (T⌬-BTg) mice were generated by breeding homozygous BAFF Tg and ␤ ␦ TCR Ϫ/Ϫ mice and F1 interbreeding. Experimental animals were double-homozygous for the BAFF transgene and the ␤ ␦ TCR Ϫ/Ϫ mutation. The BAFF transgene was determined using PCR and Southern blot assays on genomic tail snip DNA, as previously described ( 21 ) . ␤ ␦ TCR Ϫ/Ϫ status was determined by FACS MRL-lpr mice crossed onto BAFF-R mutant mice show impaired B cell development, but develop SLE ( 65 ) . In the MRL-lpr SLE model, the pathogenic mechanism through TLR7 is linked to its role in T cell activation ( 47 ) . In BAFF Tg mice, we showed that pDC activation was not altered and that IFN ␣ production was undetectable, leaving pDC involvement as an unlikely mechanism for potentiating the autoimmune process. We did not see an alteration of other immune cells, such as NK cells or granulocytes, in BAFF Tg mice (unpublished data). Interestingly, we have reported that B1 B cells are particularly associated with nephritis in BAFF Tg mice ( 23 ) , and our results here showed that TLR7 activation, more than TLR9, up-regulated TACI expression on B1 B cells. Therefore, it is possible that TLR7 may play a more dominant pathogenic role in the BAFF Tg model of nephritis, via the promotion of TACI-dependent responses by autoreactive B cells to T cell -independent signals. Generating mice with multiple TLR mutations will be needed to address this point.
We confi rmed the importance of TLR-associated MyD88-dependent signaling in driving B cell activation in BAFF Tg mice, using MyD88 Ϫ/Ϫ BM -reconstituted BAFF Tg mice in which B cell activation, secretion of pathogenic autoantibody isotypes, and C3 fi xation in the kidneys were all reduced. We also showed that MyD88 expression in B cells is important to drive kidney disease in BAFF Tg mice. The MyD88 adaptor is also recruited by receptors of IL-1, -18, and -33 ( 52, 53 ) . We have no evidence that expression of these cytokines is abnormal in BAFF Tg mice (unpublished data). The biology of IL-18 and its role in SLE is strongly associated with activation of Th1 T cells ( 66 ) , and as disease in BAFF Tg mice is clearly T cell independent, IL-18 production is an unlikely link. IL-33 is not a likely candidate for ANA or anti-dsDNA antibody detection, respectively. FITC anti -mouse Ig (BD Biosciences) was used to detect mouse antibodies. Slides were analyzed by fl uorescent microscopy (Leica) at 128ϫ magnifi cation.
Organ pathology. Kidneys and salivary glands were fi xed with 4% paraformaldehyde in PBS and embedded in paraffi n. 4 m paraffi n-embedded sections were dewaxed and stained with hematoxylin and eosin (HE). For Ig and complement C3 deposition, tissues were snap frozen embedded in Tissue-Teck OCT compound (Sakura). 5-m sections were fi xed with acetone and blocked with 5 g/ml purifi ed rat anti -mouse CD16/CD32 (BD Biosciences) and 5 g/ml polyclonal human IgG (Biogen-Idec) in PBS for 10 min before staining with FITC-conjugated anti -mouse Ig isotypes (BD Biosciences) or FITC-conjugated anti -mouse C3 (Cedarlane Laboratories).
TLR stimulation. TLR ligands used were as follows: 1 g/ml peptidoglycan (stimulating TLR2); 1 g/ml polyinosinic-polycytidylic acid (poly[I:C]; TLR3); 0.25 g/ml LPS (TLR4); 0.5 g/ml R848 (TLR7); and the CpG sequences ODN 1826 (0.5 g/ml) and ODN 2216 (1 g/ml; CpGB and CpGA, respectively; TLR9; InvivoGen). 1 g/ml of recombinant murine BAFF (Apotech) was added or not with TLR ligands in B cell cultures. MZ (B220 ϩ CD23 Ϫ CD21 h i) B cells and peritoneal B1a (CD5 ϩ B220 int ) and B1b (CD5 ϩ B220 int ) B cells were sorted using a FACSAria (BD Biosciences).
Statistical analysis. Statistical signifi cance was determined using a Student ' s t test. Values are shown for data that reached a signifi cance of P Ͼ 0.05.
Online supplemental material. Fig. S1 confi rms lack of T cells in the T⌬-BTg mouse line. Fig. S2 shows autoreactive IgG subclasses produced in T⌬-BTg mice. Fig. S3 shows IgG subclass deposition in kidneys and salivary glands of BAFF Tg and T⌬-BTg mice. Fig. S4 shows that BAFF enhanced TLR-mediated IgG switching, increased TLR7/9 mRNA expression in Fo and MZ, but not B1, B cells after BAFF stimulation, and increased levels of BAFF in the serum of MyD88 Ϫ/Ϫ mice. Fig. S5 shows MyD88 ϩ/ϩ and MyD88 Ϫ/Ϫ BAFF Tg BM chimeras and the DC phenotype in BAFF Tg mice. Fig. S6 shows that anti-dsDNA antibody production is similar in BAFF Tg mice reconstituted with TLR9 ϩ/ϩ or TLR9 Ϫ/Ϫ BM. The online version of this article is available at http://www.jem.org/cgi/content/full/jem.20062567/DC1. Flow cytometry. Mice were killed by cervical dislocation. Lymphocyte suspensions were obtained from tissues by mechanical disruption. Peripheral blood lymphocytes were isolated by density gradient centrifugation of EDTA-treated blood over Ficoll-Paque PLUS (GE Healthcare). Erythrocytes were removed from spleen samples by osmotic cell lysis solution (8.34 mg/ml ammonium chloride, 0.84 mg/ml sodium bicarbonate, and 1 mM EDTA, pH 8.0). Leukocytes were resuspended in FACS buff er (1% BSA and 0.02% sodium azide in PBS). Fluorescent-labeled anti -mouse antibodies CD1d, CD4, CD5, CD8, CD11c, CD21/CD35, CD25, CD44, CD45R/ B220, CD62L, CD69, CD80, MHC class II, IgD, IgM, IgA, IgG subclasses (BD Biosciences) CD3, CD23, CD93 (eBioscience), BAFFR, TACI, BCMA (R & D Systems), and PDCA-1 (Miltenyi Biotec) were used for FACS and/or microscopy analysis. Intranuclear staining for FoxP3 was performed according to the manufacturer ' s instructions (eBioscience). Data was collected on a LSRII fl ow cytometer (BD Biosciences), and analyzed using FlowJo software (Tree Star, Inc.). T cell subsets were determined as follows: double-negative thymocytes (CD3 Ϫ CD4 Ϫ CD8 Ϫ ); naive (CD44 Ϫ CD62L ϩ ); eff ector (CD44 ϩ CD62L Ϫ ); T reg cells (CD3 ϩ CD4 ϩ CD25 ϩ FoxP3 ϩ ). B cell populations were gated as follows: T2-MZ (B220 ϩ CD23 ϩ CD21 hi IgM hi CD93 int IgD ϩ ); T2-Fo (B220 ϩ CD23 ϩ CD21 dull IgM hi CD93 hi IgD ϩ ); Fo (B220 ϩ CD23 ϩ IgM ϩ CD21 int IgD ϩ ); MZ (B220 ϩ CD23 Ϫ/lo CD21 hi IgM ϩ CD1d hi ); B1a (B220 int IgM ϩ CD5 ϩ IgD int ); B1b (B220 int IgM ϩ CD5 Ϫ IgD int ). DC populations were gated as follows: mDCs (CD11c hi PDCA01 Ϫ B220 Ϫ ) and pDCs (CD11c int PDCA-1 ϩ B220 int ).
Immunizations. For T cell -independent type 2 (TI-2) antigen, mice were immunized i.v. with 30 g NP-coupled Ficoll (NP59-aminoethyl carboxymethyl-Ficoll; Biosearch Technology). T cell -dependent antibody responses in control littermates and T Δ -BTg mice were examined by i.p. immunization with 5 g NP-OVA (Biosearch) emulsifi ed in CFA (Sigma-Aldrich), followed by a boost immunization with 5 g NP-OVA in IFA 21 d later.
ELISA. ELISA plates were coated with 2 g/ml of goat anti -mouse Ig (H+L; Jackson Immunoresearch Laboratories), or normal goat Ig (Jackson Immunoresearch Laboratories), or 10 g/ml methylated BSA (Calbiochem) for total Ig, RF, and anti-DNA levels, respectively. For anti-DNA assays, 2 g/ml dsDNA or ssDNA prepared from grade I calf thymus (SigmaAldrich), as previously described ( 19 ) , was used to coat ELISA plates. Purifi ed mouse Ig (Southern Biotechnology) was used as standards in total Ig isotype analysis. NP-specifi c antibodies were determined by ELISA ( 22 ) . ELISA plates were coated with 2 g/ml NP 30 -BSA (Biosearch). Titer (log base 2) is defi ned as the serum dilution giving an OD reading 4 times higher than background (where 1 = 1/50). ELISAs were detected with anti -mouse isotype-specifi c alkaline phosphatase -labeled antibodies (Southern Biotechnology), and revealed by P -NP phosphate substrate (Sigma-Aldrich).
ANA and anti-dsDNA immunofl uorescence. Serum obtained by tail bleed from 8-mo-old mice was diluted in PBS 1:50 and used for indirect immunofl uorescence on fi xed Hep-2 or C. luciliae slides (Antibodies, Inc.)
